Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Figure 3 Disease-free survival.
Median disease-free survival was 52 d. There was no statistical difference between angiosarcoma and undifferentiated sarcoma groups.
- Citation: Kim SJ, Rhu J, Kim JM, Choi GS, Joh JW. Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience. World J Hepatol 2021; 13(5): 584-594
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.584